Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02637687
Title A Study to Test the Safety and Efficacy of the Drug Larotrectinib for the Treatment of Tumors With NTRK-fusion in Children (SCOUT)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Bayer
Indications

congenital fibrosarcoma

Advanced Solid Tumor

breast secretory carcinoma

benign neoplasm

congenital mesoblastic nephroma

central nervous system cancer

Therapies

Larotrectinib

Age Groups: adult | child
Covered Countries USA | CAN


No variant requirements are available.